Orchid Pharma Ltd.
| BSE: 524372 | Sector: Health care |
| NSE: ORCHPHARMA | ISIN Code: INE191A01027 |
| BSE 16:00 | 24 Sep | 415.65 |
2.30 (0.56%) |
OPEN
406.00 |
HIGH
420.00 |
LOW
402.00 |
| NSE 15:59 | 24 Sep | 418.35 |
4.95 (1.20%) |
OPEN
416.00 |
HIGH
428.00 |
LOW
407.00 |
| OPEN | 406.00 |
| PREVIOUS CLOSE | 413.35 |
| VOLUME | 1759 |
| 52-Week high | 2680.00 |
| 52-Week low | 18.00 |
| P/E | |
| Mkt Cap.(Rs cr) | 1,697 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Orchid Pharma Ltd. (ORCHPHARMA) - Financial Overview
Particulars ( cr) |
2021 | 2020 | 2019 |
| Net Sales | 450.70 | 481.21 | 583.65 |
| Operating Profit | 43.96 | -25.71 | 35.55 |
| Other Income | 6.48 | 24.28 | 217.86 |
| Interest | 52.21 | 6.22 | 6.68 |
| Depreciation | 108.90 | 117.91 | 129.92 |
| Profit Before Tax | -117.15 | -149.84 | -101.05 |
| Tax | 0.00 | 0.00 | 0.00 |
| Profit After Tax | -117.15 | -149.84 | -101.05 |
| Share Capital | 40.82 | 40.82 | 88.96 |
| Reserves | 640.52 | 757.01 | -843.95 |
| Net Worth | 681.34 | 797.83 | -754.99 |
| Loans | 464.28 | 578.18 | 3237.66 |
| Gross Block | 1175.97 | 1246.98 | 1424.57 |
| Investments | 15.43 | 0.34 | 0.47 |
| Cash | 18.97 | 172.32 | 324.17 |
| Debtors | 131.96 | 66.38 | 140.73 |
| Net Working Capital | 452.38 | 492.20 | 1042.69 |
| Operating Profit Margin (%) | 9.75 | -5.34 | 6.09 |
| Net Profit Margin (%) | -25.99 | -31.14 | -17.31 |
| Earning Per Share (Rs) | -28.70 | -36.71 | -11.36 |
| Dividend (%) | 0.00 | 0.00 | 0.00 |
| Dividend Payout | 0.00 | 0.00 | 0.00 |
Quick Links for Orchid Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
